Park Medi World PARKHOSPS Avendus Spark INDX Conference 2026
NiveshIQ
NSE: PARKHOSPS · Healthcare
Park Medi World Ltd.
₹223.87▲ ₹4.17 (+1.90%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on PARKHOSPS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Park Medi World Ltd.
Park Medi World Limited operates a network of NABH‑accredited multi‑specialty hospitals under the Park brand, offering a comprehensive range of services from cardiac and neurosciences to orthopaedics, oncology and robotic surgery. The company’s revenue of ₹1,756 Cr in the latest fiscal year was driven by high‑volume procedures such as joint replacement, bariatric surgery and kidney transplant, with a net income of ₹283 Cr reflecting efficient cost management. Recent tax department verification visits have been announced, but the company states operations remain unaffected and there is no impact on patient care or revenue streams. In a competitive Indian healthcare market, Park Medi World differentiates itself through advanced technology like iMARS robotic surgery and a strong focus on pati
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,229 Cr -1.90% | ₹1,392 Cr +13.20% | ₹1,679 Cr |
| EBITDA Margin | 27.52% | 29.01% | 26.46% |
| Net Profit | ₹153.49 Cr -30.10% | ₹205.16 Cr +33.70% | ₹258.12 Cr |
| EPS | ₹3.55 | ₹4.75 | ₹6.87 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Park Medi World Limited Estimates – NSE:PARKHOSPS
Park Medi World (PARKHOSPS.NS) Eases 1.19% to ₹215.1, Holding Mid-Range Between ₹204.34 and ₹225.85 - Rounding Top
🔒
+ 3 more stories about Park Medi World Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹476 Cr, PAT ₹83 Cr, EPS ₹2.05, EBITDA margin 26.5%. Growth context: revenue YoY +19.0%, PAT YoY +35.0%, revenue QoQ +3.3%, PAT QoQ +16.4%.
Management commentary points to new capacity addition and capex deployment and new product launches and market entry as ...
FY26 (last completed FY): revenue ₹1, 679 Cr, PAT ₹258 Cr, EBITDA margin 26.5%, EPS ₹6.87. Management guidance for FY27 ...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for PARKHOSPS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track PARKHOSPS alongside your other holdings
Unlock full PARKHOSPS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Park Medi World Ltd.?
NiveshIQ detects active intelligence signals for Park Medi World Ltd. (PARKHOSPS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Park Medi World Ltd.?
Park Medi World Ltd. operates in the Healthcare sector with a market capitalisation of ₹984,154.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.